Yahoo Web Search

  1. Ads
    related to AbbVie Inc
  1. AbbVie's Brain Cancer Candidate Fails in Phase III Study

    Zacks via Yahoo FinanceMay 20 13:02 PM

    AbbVie, Inc. ABBV announced that a late-stage study evaluating its pipeline candidate, depatuxizumab mafodotin (Depatux-M) failed to show any survival benefit in patients with ...

  2. Top Ranked Income Stocks to Buy for May 21st

    Zacks via Yahoo FinanceMay 21 11:47 AM

    Here are four stocks with buy rank and strong income characteristics for investors to consider today, May 21st: Aegon N.V. (AEG): This provider of insurance, pensions, and asset management services ...

  3. An independent data monitoring committee recommended the study be stopped due to "lack of survival benefit" for patients receiving the treatment Depatux-M when compared with a placebo, AbbVie ...

  4. This week the FDA granted quite a few approvals for line extensions of Lilly LLY, Pfizer PFE and Roche RHHBY/AbbVie’s ABBV cancer drugs. In other news, Bayer BAYRY was fined $2 billion ...

  5. AbbVie Inc said on Friday it has halted enrollment of patients in all ongoing studies testing its brain cancer treatment after the drug failed to meet the main goal in a late-stage ...

  6. The 55 Best Companies to Work For in Chicago

    Fortune via Yahoo FinanceMay 21 11:00 AM

    KPMG LLP Industry: Professional Services U.S. employees: 30,373 U.S. revenue: $8,958,000,000 Headquarters: New York, New York Employees say: “The people, a commitment to personal and professional ...

  7. Roche Gets FDA Nod for Venclexta Plus Gazyva to Treat CLL

    Zacks via Yahoo FinanceMay 17 21:19 PM

    Roche Holding AG RHHBY announced that the FDA has approved its supplemental new drug application (sNDA) for Venclexta (venetoclax) in combination with Gazyva (obinutuzumab). The company is a ...

  8. Edited Transcript of APTX.OQ earnings conference call or presentation 14-May-19 12:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceMay 21 1:34 AM

    Henry is currently Executive Vice President and Chief Strategy Officer at AbbVie. He brings considerable industry expertise and insights to the team from his time at AbbVie and ...

  9. Synlogic, Inc. (SYBX) Q1 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceMay 17 1:14 AM

    This afternoon, we issued a press release which outlines our first quarter 2019 financial results and several other topics that we plan to discuss today. Joining me on this call today are Aoife ...

  10. Dova Pharmaceuticals, Inc. (DOVA) Q1 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceMay 15 3:48 AM

    Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those in the risk factors section of the company's ...

  1. Ads
    related to AbbVie Inc